In this study, we evaluated the effect of oral administration of riboflavin combined with whole-body ultraviolet A (UVA) irradiation on the biochemical and biomechanical properties of sclera in a guinea pig model to control the progression of myopia. Experimental groups were administered 0.1% riboflavin solution with or without vitamin C by gavage from 3 days before myopic modeling and during the modeling process. Guinea pigs underwent 30 min of whole-body UVA irradiation after each gavage for 2 weeks. For control groups, guinea pigs were administered vitamin C and underwent either whole-body UVA irradiation without 0.1% riboflavin solution or whole-body fluorescent lamp irradiation with or without 0.1% riboflavin solution. Resultantly, myopia models were established with an increased axial length and myopic diopter. Compared with myopic eyes in the control groups, the net increase in axial length, diopter and strain assessment decreased significantly, and the net decrease in sclera thickness, ultimate load, and stress assessment decreased significantly in experimental groups. MMP-2 expression showed a lower net increase, while TIMP-2 expression showed a lower net decrease. In addition, hyperplasia of scleral fibroblasts was more active in myopic eyes of experimental groups. Overall, our results showed that oral administration of riboflavin with whole-body UVA irradiation could increase the strength and stiffness of sclera by altering the biochemical and biomechanical properties, and decreases in axial elongation and myopic diopter are greater in the guinea pig myopic model.
Introduction
Myopia is a significant public health problem with an increasing prevalence, and it is the leading cause of correctable visual impairment in children and adults in the developed world and one of the main causes of blindness in developing countries (Robaei et al., 2006; Lu et al., 2009; Vitale et al., 2008; Resnikoff et al., 2008) . In China, there is a high prevalence of myopia, with an average morbidity of more than 75% in young adults aged 15e25 years (Holden et al., 2014) .
Myopia, particularly high myopia, is associated with major ophthalmic diseases that can eventually lead to blindness, such as exudative myopic macular degeneration, rhegmatogenous retinal detachment, myopic retinopathy, and glaucoma. The mechanism of myopia is not completely understood, but many researchers believe that the sclera behaves as a "metabolic disorder" (McBrien and Gentle, 2003) . Various inborn and postnatal factors cause the sclera to be thin and expand under eye pressure, leading to eyeball deformations such as localized ectasia of the posterior sclera, which results in myopia. Animal studies of experimental myopia have shown that scleral tissue from myopic eyes decreases mechanical stiffness and increases creep compliance compared with scleral tissue from normal eyes (Phillips et al., 2000) . The concept of enhancing the strength and stiffness of the sclera to stabilize the normal morphology of ocular tissue has attracted significant research interest in recent years.
Wollensak and Iomdina reported stressestrain measurements of a sector of the equatorial sclera of Chinchilla rabbit eyes, which was treated in vivo with ultraviolet A (UVA) irradiation and riboflavin drops, and proposed that scleral collagen cross-linking induced by UVA and riboflavin may increase biomechanical strength and scleral rigidity (Wollensak and Iomdina, 2009) . Another study investigated the in vitro ultrastructural effects of a collagen cross-linking treatment with riboflavin instilled into the strips prior to UVA irradiation in human corneo-scleral collagen fibrils and found that this method causes structural changes in the collagen fibril network of the sclera (Choi et al., 2013) . Riboflavinsensitized photoreaction generates free radicals and reactive oxygen species, such as singlet oxygen, superoxide, or superoxide anion radicals to induce cross-linking of collagen under UVA (Wollensak and Spoerl, 2004; Wollensak et al., 2005) . Scleral collagen cross-linking by riboflavin/UVA is a novel technique to enhance scleral mechanical strength, and may provide an ideal approach for strengthening scleral tissue, thereby suppressing myopic progression. However, these experiments using riboflavin and UVA require a surgical operation to expose the sclera with a limited irradiation area. At this time, further studies are required for this intervention to be clinically applicable. Thus, we evaluated the effects of whole-body UVA irradiation plus oral administration of riboflavin on the biochemical and biomechanical properties of sclera in myopic guinea pigs to develop a unique, non-invasive, and practical therapy to control the progression of myopia. This is the first report to investigate the effect of whole-body UVA irradiation and riboflavin without surgical exposure of the sclera in myopic eyes.
Materials and methods

Animals and treatments
All animal experiments conformed to "Regulations of Animal Experiments in Zhejiang Province" and were approved by Zhejiang Chinese Medical University. A total of 30 guinea pigs (all females, four-weeks old) were treated with a À10.0 D concave lens on the right eye for two weeks to establish the myopic model. The concave lens was a À10.00 D poly(methyl methacrylate) (PMMA) lens (Shanghai Freshkon Contact Lenses Co., Ltd., China) with a diameter of 11.00 mm and inner arc curvature of 9.00 mm (Fig. 1) . All guinea pigs were randomly divided into five groups (n ¼ 6 in each): group A (vitamin C þ whole-body fluorescent lamp irradiation, control group), group B (vitamin C þ whole-body UVA irradiation, control group), group C (vitamin C þ riboflavin þ whole-body fluorescent lamp irradiation, control group), group D (vitamin C þ riboflavin þ whole-body UVA irradiation, experimental group), and group E (riboflavin þ whole-body UVA irradiation, experimental group). As mentioned above, all guinea pigs were fed a basal diet and 100 mg of vitamin C or 0.4 mg riboflavin in 0.1% solution by gavage three times per day from three days before the beginning of establishing myopia models to two weeks after the modeling. During the modeling period, animals underwent fluorescent lamp irradiation (30 cm from above) or UVA irradiation (370 ± 5 nm) using a UVA device (Changjiang Medical Devices Co., Ltd, China) with an irradiance of 3.0 mW/cm 2 at a distance of 30 cm for wholebody irradiation. For fluorescent lamp irradiation, the irradiation started after each gavage and the total daily irradiation time was 8 h; for UVA irradiation, the irradiation started after each gavage and lasted for 30 min, and the total daily irradiation time was 1.5 h. The right eye of each animal served as the lens-induced eye and the contralateral left eye served as the control eye.
Diopter and ocular axial length measurements
After general anesthesia by injecting ketamine hydrochloride into the thigh muscles, the axial length was measured with A-Node Ultrasonic Diagnostic Equipment (Meda Co., Ltd, China). Retinoscopy optometry (Fizz Kang Visual Light Company, China) was used to examine the diopter after cycloplegic pre-and post-experiments.
Biomechanical measurements
Guinea pigs were killed after two weeks and eyes were put into preservation solution and cryopreserved in liquid nitrogen after enucleation, after which the eyes were rewarmed rapidly in a 37e38 C water bath. Stressestrain tests were performed for sclera specimens using a microcomputer-controlled biomaterial tester (Instron Test Equipment Trade, Ltd, USA). The 15 mm Â 4 mm scleral strips were clamped horizontally with a stress level of 0.005e0.04 N, and the strain was increased linearly at a velocity of 5 mm/min to test the tensile strength until the specimen broke. The ultimate load, ultimate stress, and ultimate strain were recorded using the microcomputer-controlled tester over time for further analysis.
Posterior sclera thickness
After removing the vitreous, retina, and surrounding connective tissue, scleral tissue (diameter, 6 mm) taken from the posterior sclera was immediately immersed in 4% paraformaldehyde to be fixed for 24 h, after which the sample was dehydrated and paraffinembedded to make a 4-mm section of the sclera; thin 4-mm sections were stained with hematoxylin and eosin and periodic acid-Schiff (PAS). A Zeiss light microscope (Axiomat, Zeiss, Oberkochen, Germany) was used to measure the specimens (scleral tissue thickness in the central region) at various magnifications.
Western blotting
Tissue homogenate was produced from 3 mm Â 4 mm sections of posterior scleral tissue (100 mg) with 0.5e1 mL of cold lysis buffer, after which it was centrifuged at 4 C and 10,000 rpm for 5 min. The protein concentrations were determined using bovine serum albumin (BSA) as standards based on the Bradford assay (Bio-Rad, BioTek Instruments, Inc. USA). The protein solution was then separated by 10% polyacrylamide gel electrophoresis with 5% stacking gels with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The separated proteins were transferred onto nitrocellulose membranes, after which the membranes were washed in Tris-buffered saline with 0.1% Tween-20 (TBS-T) and blocked in plates with diluted matrix metalloproteinase-2 (MMP-2) antibody BA0569 (Wuhan Boster Biological Technology, LTD., China) or tissue inhibitor of MMP-2 (TIMP-2) antibody BA0576 (Wuhan Boster Biological Technology, LTD., China) for 10e12 h at 4 C. Membranes were then washed three times in TBS-T and Fig. 1 . Guinea pig models of lens-induced myopia. A: A single-use Murphy dropper was pruned to construct a frame and the concave lens was agglutinated to the selfmade spectacle. B: The self-made spectacle was sutured and fixed to the right eye of the guinea pig. incubated with secondary antibodies for 1 h at 26 C, after which they were washed another three times in TBS-T. Protein blots on the membranes were then enhanced by chemiluminescence (ECL Detection Kit, Beyotime, China) and exposed using the FluorChem E System. Films were scanned into digital images and the primary densities of the band of MMP-2, TIMP-2, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were measured with Quantity One (Bio-Rad).
Transmission electron microscopy
A small mark was made at the temporal corneal limbus using an indelible ink marker pen to allow for orientation of the eye cup after enucleation. Eyes were immersed in 0.05 M cacodylic acid sodium and 2.5% glutaraldehyde with phosphate buffer saline (pH 7.4) for 2 h. After this period, the cornea and lens were dissected, leaving the mark in the limbal region. A cornea trephine (diameter, 6 mm) was then used to punch out a posterior tissue button (containing retina, choroid, and sclera). Two 2 mm Â 1 mm strips of sclera tissue were excised from the tissue button near the nasal region, 1 mm from the optic nerve with razor blades. The strips were immersed in 0.05 M cacodylic acid sodium and 2.5% glutaraldehyde for 24 h. Tissue samples were post-fixed in 1% osmium tetroxide with phosphate buffer saline (pH 7.4) for 1 h at 4 C, stained with 1% uranyl acetate with double distilled water for 2 h, and then rinsed and dehydrated in graded acetone before embedding in Araldite. Scleral samples were analyzed using transmission electron microscopy.
Statistical analyses
Statistical analysis with a significance level of p < 0.05 was performed using Tukey's multiple comparisons test with SPSS software (v17.0, SPSS Inc, USA). Data are presented as mean ± standard deviation (SD).
Results
Establishment of myopia models
After two weeks, we compared pre-test and post-test parameters of ocular axial length and diopter. The results showed that all data in the lens-induced eye had significantly longer axial lengths and higher myopic diopter compared with data from the pre-test, which indicated that the myopic models were established successfully.
As shown in Fig. 2 , in control groups (A, B, C), mean axial length in the lens-induced eye was 7.37 ± 0.25 mm (A), 7.23 ± 0.19 mm (B), and 7.27 ± 0.24 mm (C) before establishing the myopic model, and 8.31 ± 0.09 mm, 8.25 ± 0.11 mm, and 8.11 ± 0.17 mm 14 days later, respectively. In experimental groups (D, E), which underwent oral administration of riboflavin and whole-body UVA irradiation, mean axial length in the lens-induced eye were 7.09 ± 0.18 mm (D) and 7.19 ± 0.11 mm (E) at day 0 and 7.94 ± 0.10 mm and 7.99 ± 0.09 mm 14 days later, respectively. The measurement of the axial lengths revealed a lower net increase in myopic eyes of experimental groups (D, E) compared with myopic eyes in control groups (A, B, C) ( Fig. 2A) . In the present study, significant differences were observed between the control and experimental groups (A vs. D, A vs. E, B vs. D, B vs. E, all p < 0.01). However, no significant difference (p > 0.05) was observed between group C and experimental groups (D, E).
In control groups (A, B, C), mean diopter in the lens-induced eye (Fig. 2B) . There was no significant difference in the axial length and diopter (p > 0.05) between groups D and E. These results demonstrated that our intervention method may suppress the development of myopia.
Posterior scleral thickness and biomechanical measurements
The scleral thickness of the control eye was thicker than the lens-induced eye in all groups, as indicated in Fig. 2C . In the experimental groups (D, E), mean thickness of myopic eyes showed a significantly lower net decrease (A vs. D, A vs. E, B vs. D, B vs. E, C vs. D, C vs. E, all p < 0.01) compared with myopic eyes in control groups (A, B, C). Although no significant difference was observed between experimental groups (D, E), our results indicated that systematic whole-body UVA irradiation with oral administration of riboflavin could thicken the sclera in myopic eyes.
Compared with control eyes, the ultimate load and stress assessment were lower and the strain assessment was higher for myopic eyes in each group. Moreover, the ultimate load and stress assessment for myopic eyes in the experimental groups were significantly higher and strain assessment for myopic eyes in the experimental groups was significantly lower than myopic eyes in control groups (Fig. 2DeF) . Fig. 2D showed that after 14 days of myopic modeling, myopic eyes in experimental groups (D, E) had higher values of ultimate load than myopic eyes in control groups (A, B, C) (Fig. 2D, A 
vs. D, A vs. E, B vs. D, B vs. E, C vs. D, C vs. E, all
p < 0.01); Fig. 2E showed that after 14 days of myopic modeling, myopic eyes in experimental group D had higher values of stress assessment than myopic eyes in the control groups (A, B) (Fig. 2E , A vs. D, B vs. D, all p < 0.01); Fig. 2F showed that after 14 days of myopic modeling, myopic eyes in experimental groups (D, E) had lower values of strain assessment than myopic eyes in control groups (A, B) (Fig. 2F, A vs. D, B vs. D, all p < 0.01; B vs. E, p < 0.05). These results indicated that sclera in high myopic eyes was more flexible and its load bearing capacity was lower than emmetropia, but whole-body UVA irradiation with oral administration of riboflavin could increase the biomechanical characteristics of sclera in myopic eyes.
Protein expression level of MMP-2 and tissue TIMP-2
MMP-2 and TIMP-2 play key roles in the development of myopia. Visual signals may modulate gene expression of selected MMPs and TIMPs to control scleral remodeling, the mechanical properties of the sclera, axial elongation, and the refractive state (Siegwart and Norton, 2005) . It is believed that the increased expression of MMP-2 and the decreased expression of TIMP-2 promote myopia.
The results shown in Fig. 3 demonstrate that whole-body UVA irradiation plus oral administration of riboflavin regulates the expression of MMP-2 and TIMP-2. In the control groups (A, B, C), myopic treatment significantly increased the expression of MMP-2 (Fig. 3B) and significantly decreased the expression of TIMP-2 (Fig. 3C) , whereas in the experimental groups (D, E), myopic treatment did not significantly increase the expression of MMP-2 (Fig. 3B ) and did not significantly decrease the expression of TIMP-2 (Fig. 3C ), but actually increased the expression of TIMP-2. Overall, our results demonstrated that whole-body UVA irradiation plus oral administration of riboflavin could suppress myopia progression.
Transmission electron microscopy of scleral tissue
Transmission electron microscopy was used to detect the hyperplasia of fibroblasts in scleral tissue 14 days after treatment.
Compared with control groups (A, B, C), the density of scleral fibroblasts increased significantly in myopic eyes in the experimental groups (D, E), and more fibroblasts were present in myopic eyes in group D and E (Fig. 4) . In total, whole-body UVA irradiation plus oral administration of riboflavin could enhance the hyperplasia of fibroblasts in scleral tissue. 
Discussion
Myopia is often accompanied by decreased scleral collagen content, changes in collagen fiber diameter and distribution, and decreased scleral thickness (McBrien et al., 2001 ). Riboflavin and UVA treatment, as well as other chemical cross-linking methods such as glutaraldehyde injection (Charulatha and Rajaram, 2003) , are rarely used to control myopia due to their potential debatable roles in the sclera. The applications of these methods are limited due to the available area of irradiation, the requirement of surgical exposure of the sclera (Wollensak and Iomdina, 2009) , and the potential cytotoxic risk to the corneal endothelium, lens, and retina at an inappropriate dosage (Wollensak et al. 2003 (Wollensak et al. , 2005 Zhao et al., 2013) . Our data suggest that systematic whole-body UVA irradiation plus oral administration of riboflavin can effectively improve the structural, biochemical, and biomechanical characteristics of sclera, delaying myopic development in a guinea pig myopic model. Indeed, myopia-induced decreases in the diameter of collagen fibrils and collagen fiber bundles result in elongation and localized ectasia of the sclera (Rada et al., 2006) . Moreover, elongation of the eyes is determined mechanistically by the biochemical and biomechanical properties of the sclera (Rada et al., 2000) . Common approaches to change the biochemical and biomechanical properties of the sclera include surgical exposure of the sclera, which is invasive and painful. In this study, we attempted to identify a novel approach to change the biochemical and biomechanical properties of the sclera. We showed that the oral administration of riboflavin combined with whole-body UVA irradiation without surgical exposure of the sclera and direct UVA irradiation on the sclera could suppress axial length elongation and myopic diopter incerasing in a guinea pig myopic model.
Pathological changes in the sclera with progressive scleral thinning and a decreased biomechanical extensibility are important features and common causes of severe myopia (McBrien and Gentle, 2003; Rada et al., 2006) . Choi et al. suggested that the collagen cross-linking technique induced by riboflavin and UVA leads to increases in the density, area, diameter, and thickness of human scleral tissues (Choi et al., 2013) . In the present study, the experimental groups with oral riboflavin and whole-body UVA irradiation showed a lower net decrease in the development of myopia, especially in scleral thickness and ultimate load, suggesting that our method may be associated with scleral collagen crosslinking in the myopic eye.
During the development of myopia, the sclera undergoes active remodeling that involves the regulation of MMPs and TIMPs (Kim et al., 2001; Shelton and Rada, 2007) . Therefore, the expression variations of these two proteins among the groups were evaluated in our myopic model. Increased scleral MMP-2 expression in formdeprivation myopia has been observed in guinea pigs at the protein level (Wang et al., 2010) . Meanwhile, MMP-2 can be controlled by numerous factors including down-regulation of the expression of specific proteins, such as TIMPs (Siegwart and Norton, 2002) . Biomechanical scleral changes in myopia include of a net loss of the matrix induced by increases in levels of both latent and active MMP-2 (Rada et al., 2006; Guggenheim and McBrien, 1996) . These results were confirmed in the present study, showing that the expression of MMP-2 increased and the expression of TIMP-2 decreased in lens-induced eyes. Interestingly, myopic eyes in the experimental groups showed a lower net increase in MMP-2 and a lower net decrease of TIMP-2, suggesting that our method does not strongly affect the sclera. However, further studies are required to explore the underlying mechanisms.
Based on electron microscopy, the sclera consists of fibroblasts and collagen bundles, which can increase strength through changes in the biomechanical properties of the sclera. In myopic eyes in our control groups (A, B, C), the diameter of the posterior sclera fibroblasts was thinner compared with that of myopic eyes in experimental groups (D, E), and there was vacuolar degeneration in the fibroblasts. A previous report showed that the major differences were in morphology and in the diameter of fibroblasts in the posterior sclera between normal and myopic eyes (Liu et al., 1986) , which agrees with our results.
According to the above reports, riboflavin, no systemic side effects, can increase the absorption of UVA to limit the damage of UVA to ocular tissues under the appropriate doses during collagen cross-linking (Zhao et al., 2013) . However, no reports have provided the exact dose of orally administered riboflavin, which is important to ensure that the concentration in the sclera is sufficient to have a therapeutic effect.
The effects of UVA on the retina were a concern during this study. Thus, the parameters of UVA irradiation were carefully selected. Wollensak and Iomdina (2009) confirmed that there were no side effects on the retina or retinal pigment epithelium using UVA under 370 nm and 3 mW/cm 2 . Moreover, UVA was applied for collagen cross-linking at 370 nm, where riboflavin absorption peaks and there is no evidence of tissue damage in this band (Zhao et al., 2013) . Therefore, in this study, UVA at 370 nm and 3 mW/cm 2 were selected and UVA irradiation was applied using a whole-body irradiation approach. Vitamin C, unlike other antioxidants, does not absorb radiation in the UVA range (Ou-Yang et al., 2004) and can slow the absorption and degradation of riboflavin (Lee et al., 1998) . Moreover, vitamin C can counteract DNA damage and mutagenesis induced by the UVA and riboflavin (Besaratinia et al., 2007) . Therefore, the possibility of vitamin C to interfere with the optical effects of UVA and riboflavin could be ruled out. The protective effects of vitamin C observed in this study may be ascribed to its antioxidant and free radical scavenging capacities (Catani et al., 2005) .
In summary, we present the first in vivo study on decreasing axial length elongation and limiting increases in myopic diopter in a guinea pig myopic model using non-invasive oral administration of riboflavin combined with whole-body UVA irradiation. The Fig. 4 . Photomicrograph of the sclera in different groups demonstrating the hyperplasia of fibroblasts at 14 days after myopic treatment. Arrows indicate the aggregation and cellular bundles of fibroblasts in the sclera.
above combinative intervention led to significant changes in protein levels of MMP-2 and TIMP (related to scleral remodeling) and biomechanical rigidity of the sclera in the myopic model mentioned above. In our study, we found no significant difference in the axial length, stress assessment and strain assessment between group C with experimental groups (D, E). It is known that the wavelength of fluorescent lamps range from 400 to 700 nm (Pasquale et al., 2017; Karin et al., 2017) . Within this field, some wavelengths of light may have an effect, similar to UVA (370 ± 5 nm), to delay myopic development with the oral administration of riboflavin. Further systemic studies are required to determine the underlying mechanisms, address the potential toxicity (such as impairment of the retina), and develop protective solutions (such as protection of the retina).
